Search

Displaying results 91 - 100 of 108 in total
  1. Drug

    Motixafortide

    go.drugbank.com/drugs/DB14939
    ApprovedInvestigational

    [L48141] It has also been investigated alongside [pembrolizumab] for the treatment of pancreatic cancer.[A261481]

  2. Indication

    Locally Advanced or Metastatic Urothelial Carcinoma (UC)

    go.drugbank.com/conditions/DBCOND0123651
    Drugs: Enfortumab vedotin · Erdafitinib · Pembrolizumab · Sacituzumab govitecan
  3. Indication

    Resectable Non-small Cell Lung Cancer

    go.drugbank.com/conditions/DBCOND0068626
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  4. Indication

    Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    go.drugbank.com/conditions/DBCOND0144294
    Drugs: Cetuximab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  5. Drug

    Nadofaragene firadenovec

    go.drugbank.com/drugs/DB17381
    ApprovedInvestigational

    Compared to [pembrolizumab], a smaller proportion of patients experienced grade 3-4 adverse events (4% vs 12.7%).[A255111]

  6. Indication

    Metastatic Renal Cell Carcinoma ( mRCC)

    go.drugbank.com/conditions/DBCOND0123126
    Drugs: Aldesleukin · Bevacizumab · Medroxyprogesterone acetate · Nivolumab · Pembrolizumab
  7. Indication

    Non-Small Cell Lung Cancer (NSCLC)

    go.drugbank.com/conditions/DBCOND0034130
    Drugs: Etoposide · Irinotecan · Mitomycin · Paclitaxel · Pembrolizumab · Vinblastine
  8. Drug

    Pemetrexed

    go.drugbank.com/drugs/DB00642
    ApprovedInvestigational

    Pemetrexed is a chemotherapy drug that is manufactured and marketed by Eli Lilly and Company under the brand name Alimta. It is indicated for use in combination with cisplatin for the treatment of patients with malignant pleural mesothel...

  9. Indication

    Metastatic Squamous Cell Carcinoma of the Head and Neck (HNSCC)

    go.drugbank.com/conditions/DBCOND0138147
    Drugs: Cetuximab · Docetaxel · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab
  10. Indication

    Metastatic Urothelial Carcinoma (UC)

    go.drugbank.com/conditions/DBCOND0073677
    Drugs: Durvalumab · Hyaluronidase (human recombinant) · Nivolumab · Pembrolizumab · Pemetrexed